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nearest whole number. The median DVH value of new 
genitalia contours denotes the optimal constraint and the 
75th centile denotes the mandatory constraint. Horizontal 
lines represent current genitalia dose constraints. It can be 
observed that new recommended dose constraints contrast 
the current dose constraints highlighting the need for gender 
and tumour stage specific genitalia dose constraints. 
 
 
 
 
 
Conclusion: Dosimetric differences exist between genders 
and between patients with and without involved nodes when 
defining genitalia contours with aid of an atlas. Current 
generic set of genitalia dose constraints are inappropriate 
and gender/tumour stage specific constraints have been 
recommended. 
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Purpose or Objective: The clinical target volume (CTV) in 
rectal cancer is subject to large deformations. These 
deformations result in large margins when a planning target 
volume (PTV) is constructed with a population based method. 
A preferred approach uses a library of plans (LoP) and is 
expected to result in smaller PTV margins. A LoP requires a 
selection of the best fitting plan based on a Cone Beam CT 
(CBCT) scan. This triggers the questions: ‘Is the visibility of 
the target volume sufficient for plan selection? ’ and ‘ Do the 
plan selection choices of Radiation Therapists (RTT) 
coincide?’ The purpose of this study is to determine 
feasibility in plan selection for a LoP in radiotherapy of rectal 
cancer. 
 
Material and Methods: Thirty rectal cancer patients were 
included in this retrospective study. All patients received a 
radiation dose of 25 Gy in 5 fractions of 5 Gy, with on-line 
position verification. Instructions for the patient on the 
planning-CT were: full bladder and empty rectum The CTV 
was defined on the planning-CT (pCT) and contained the 
mesorectum, presacral area, pelvic lymph node areas and 
gross tumor volume (GTV). From the this single CTV a library 
of CTVs was constructed with in-house built software using 
population statistics on daily rectal deformations. The library 
consisted of five plans: two larger, two smaller and the 
original plan, see figure. We performed a baseline 
measurement with 4 observers (all RTTs). The observers 
separately selected plans on 150 CBCT scans based on a priori 
set of instructions (Observer study I). The study was followed 
by multiple consensus meetings with an experienced 
radiation oncologist to discuss deviating choices and refine 
the instructions. A golden standard was determined for each 
scan. After 5 months the observers were asked to reevaluate 
the same set of scans based on the refined guidelines 
(Observer study II). 
 
 
 
Results: Observer study I: The scan quality was determined 
to be sufficient for plan selection. In 69 % of the cases the 
observers were in accordance with the gold standard. 29 % of 
all selections deviated by 1 plan and 2% deviated by 2 plans. 
The consensus meeting revealed that inconsistency in choices 
arose from inadequate instructions. For instance, should an 
air pocket rather far from the GTV also be covered within the 
CTV? Instructions were clearified, and more 
specified.Observer study II: In 87% of the cases the observers 
were in accordance with the gold standard and 13% of all 
selections deviated by 1 plan. 
 
Conclusion: The observer study showed a good consistency in 
selecting the plan that would fit best on the anatomy of that 
day, even given the suboptimal CBCT image quality. 
Clinically, the occasional selection of a plan that deviates by 
one from the gold standard is deemed acceptable by the 
radiation oncologist. Therefore, plan selection based on daily 
CBCT by RTT for rectum patients is feasible, albeit room for 
improvement remains. 
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Purpose or Objective: In our department, bladder cancer 
patients with solitairy muscle-invasive bladder tumor are 
standardly treated with adaptive radiotherapy treatment 
S224                                                                                     ESTRO 35 2016 
 _____________________________________________________________________________________________________ 
(ART) to account for daily variations in bladder filling. Prior 
to each fraction, a conebeam CT (CBCT) is acquired and 
registered to the planning CT using a Chamfer algorithm 
(Elekta XVI 4.5). A dedicated RTT chooses the best fitting 
plan from a library of five plans. When none of the five plans 
fit the bladder volume, fine-tuning of the bony anatomy 
registration is performed (tweak), in order to optimize target 
coverage.  
A tweak introduces an inter observer error and is a 
challenging time consuming part of the online CBCT 
registration workflow. We hypothesized that the rectum 
volume had a large influence on fine-tuning. The aim of this 
study was to investigate whether a significant correlation 
exists between rectum volume and performed tweak. 
 
Material and Methods: Prior to treatment, the tumor was 
marked during cystoscopy with lipiodol or hydrogel. Two 
planning CTs were acquired: full bladder 100%; empty 
bladder 0%. A structure-based algorithm was used to create 
five different target volumes: 0%, 33%, 67%, 100%, and 133%, 
to create five different VMAT plans. The bladder and lymph 
nodes were treated to 40 Gy, the tumor up to 55 Gy, in 20 
fractions using a simultaneously integrated boost. If none of 
the plans resulted in a good coverage of the bladder volume, 
the dedicated RTT had three options. The first two options 
were to instruct the patient to drink more and/or defecate: a 
100% bladder filling is preferred. The third option was to 
perform a tweak.  
A tweak should not exceed the PTV margins: 7 mm L-R (X), 8 
mm C-C (Y) and A-P (Z) and is restricted by adequate 
coverage of the high dose area, visible through the lipiodol or 
hydrogel. This area is considered clinically more important 
compared to the elective lymph nodes. 
189 CBCTs from 10 patients were analyzed. Bladder and 
rectum volumes from both CT and CBCT were recorded. The 
differences in rectum volume between CT and each CBCT 
were calculated, as well as the mean rectum volume 
(compared to the planning CT) and the vector length of the 
tweak (see figure 1). The correlation (R²) between the 
rectum volume and the tweak vector was calculated. 
 
 
 
Results: For fractions without a tweak the mean relative 
rectum volume was 99% compared to 79% for fractions in 
which a tweak was performed. The number of times each 
plan was chosen and the times a tweak was performed are 
shown in Table 1. 
 
 
 
Conclusion: A significant correlation was found between the 
vector length of the tweak and rectum volume difference 
between full bladder CT and CBCT. Also tweaking was 
necessary less often when the rectum volume remained 
stable. Further research is necessary to identify a range of 
rectum volumes that will probably remain stable during the 
course of treatment. 
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Purpose or Objective: The traditional paradigm for inverse 
planning does not always deliver a Pareto-optimal dose 
distribution. In addition, trade-offs between different organs 
at risk are often necessary. In a clinical setting centered on 
shared decision making (SDM) between patients and their 
physicians, we suggest that individual preferences could be 
incorporated into plan selection based on a family of optimal 
plans. We present interim results from an efficient workflow 
for plan generation with trade-off selection, based on multi-
criteria optimization (MCO). 
 
Material and Methods: In this pilot study, dose plans were 
retrospectively generated for four representative anal cancer 
patients. All were treated with intensity-modulated 
radiotherapy with a standard regimen (60.2 Gy simultaneous-
integrated tumor boost with 50.4 Gy to elective nodes, in 28 
fractions, high dose regimen) and physician-defined organ-
sparing priorities. In the first alternative plan generation, we 
optimized for minimum acceptable target volume coverage 
and same organ-sparing priorities, but assumed that the 
patient voluntarily foregoes the last three fractions of the 
standard regimen (tumor and nodal dose lowered by 6.45 Gy 
and 5.4 Gy, respectively, low dose regimen). Resulting 
changes in 2-year local tumor control probability were 
estimated using a model by Muirhead et al (Radiother Oncol 
2015;116: 192–196). In the second round of alternative plan 
generation, we used MCO to search the phase space of 
optimal plans at the shorter regimen that would maximize 
sparing of the bowel at the expense of the bladder (bowel 
sparing regimen), and vice versa (bladder sparing regimen). 
In this way, we simulated the maximum span of dose 
distributions available for individualized patient preferences 
in regards to toxicity avoidance. 
 
Results: Figure 1 demonstrates dose distributions for a single 
patient for the high dose, low dose, bowel sparing, and 
bladder sparing regimen. Dose metrics for bladder and bowel 
are shown in Table 1. All dose plans had clinically acceptable 
target coverage, and were deemed satisfactory by a senior 
oncologist. Considerable reduction of dose to the bowel was 
possible, not only by reduction in prescription dose 
(ΔV45Gy=289 ccm) but also further by prioritization of bowel 
in the plan optimization (ΔV45Gy=308 ccm). This resulted in 
bladder dose metrics no better than those for the high dose 
regimen. The reverse was seen for bladder sparing plans. 
